Syntekabio Grants 250,000 Stock Options (1.03%) to Employees

Board resolved on May 15, 2026 to grant 250,000 stock options (1.03% of total outstanding shares) to employees and directors.
Exercise price set at 2,990 won, based on arithmetic average of weighted average market prices over 2 months, 1 month, and 1 week prior to board meeting (average 2,989.25 won), rounded up.
Vesting condition: requires 2 years of service from grant date; exercisable within 3 years thereafter, and must remain employed at exercise.
Fair value per option estimated at 1,563.40 won using binomial model with assumptions: volatility 71.20%, risk-free rate 3.91%, dividend yield 0%.
Total granted shares of 250,000 represent 1.03% of existing 24,258,475 shares, resulting in minor dilution.

ADVERTISEMENT (250px+)